Published in Dermatology on January 01, 2007
Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide. Oncotarget (2017) 0.76
Thalidomide in Kaposi sarcoma: promising or disappointing? Dermatology (2007) 0.75
Advances in the systemic treatment of cutaneous sarcomas. Semin Oncol (2012) 0.75
Mucosal Kaposi sarcoma, a Rare Cancer Network study. Rare Tumors (2012) 0.75
Kaposi Sarcoma in an Human Immunodeficiency Virus (HIV)-Seronegative Mediterranean Female: Report of a Rare Case. Am J Case Rep (2017) 0.75
Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol (2006) 2.54
Henoch-Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol (2002) 2.44
Kaposi's sarcoma in HIV-negative men having sex with men. AIDS (2008) 2.28
Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol (2004) 2.08
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology (2011) 2.01
Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol (2003) 1.93
Kidney transplant in black recipients: are African Europeans different from African Americans? Am J Transplant (2005) 1.88
Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol (2006) 1.74
Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transpl Int (2011) 1.73
Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int (2008) 1.71
Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura. Kidney Int (2010) 1.71
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit (2009) 1.68
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis. Joint Bone Spine (2014) 1.54
Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy (2008) 1.53
Association between endothelin receptor B nonsynonymous variants and melanoma risk. J Natl Cancer Inst (2005) 1.51
Determination of lowest possible creatinine in living-donor kidney renal transplant recipients based on donor kidney function. Transplantation (2008) 1.50
Successful renal retransplantation after post-transplant lymphoproliferative disease. Am J Transplant (2004) 1.48
In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol (2005) 1.44
Cidofovir may be deleterious in BK virus-associated nephropathy. Transplantation (2010) 1.41
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood (2009) 1.37
Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant (2003) 1.34
High-resolution boundary analysis during Arabidopsis thaliana flower development. Plant J (2004) 1.32
Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population. Hum Mutat (2008) 1.26
REBELOTE, SQUINT, and ULTRAPETALA1 function redundantly in the temporal regulation of floral meristem termination in Arabidopsis thaliana. Plant Cell (2008) 1.23
Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med (2010) 1.17
Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Arch Dermatol (2006) 1.16
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients. J Am Acad Dermatol (2008) 1.16
Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. JAMA (2008) 1.13
Replacement kidney lipomatosis after renal transplantation. Transplantation (2005) 1.12
Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant (2009) 1.11
Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation (2002) 1.11
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther (2004) 1.10
Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation (2004) 1.10
Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics. Pharmacogenomics (2011) 1.09
Clinical validation studies of Neoral C(2) monitoring: a review. Transplantation (2002) 1.08
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol (2014) 1.08
Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation (2011) 1.06
Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Clin Pharmacol Ther (2002) 1.06
Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol (2003) 1.06
Quality of abstracts in 3 clinical dermatology journals. Arch Dermatol (2003) 1.05
Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy. Am J Transplant (2005) 1.04
Time to stop: flower meristem termination. Plant Physiol (2009) 1.03
Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study. Transplantation (2010) 1.03
Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine. Transplantation (2007) 1.02
Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis. AIDS (2010) 1.01
Unusually diffuse idiopathic calcinosis cutis. Clin Rheumatol (2006) 0.99
Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int (2002) 0.99
Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. Kidney Int (2005) 0.99
Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries. Am J Kidney Dis (2009) 0.99
HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Int J Cancer (2002) 0.97
Renal transplantation in patients with sarcoidosis: a French multicenter study. Clin J Am Soc Nephrol (2010) 0.97
Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry (2014) 0.95
Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection. Cancer (2006) 0.95
Use of Neoral C monitoring: a European consensus. Transpl Int (2005) 0.94
Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation (2004) 0.93
Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist. Clin J Am Soc Nephrol (2010) 0.91
Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death. Am J Physiol Renal Physiol (2008) 0.91
MADS-box genes and floral development: the dark side. J Exp Bot (2012) 0.90
New computerized color image analysis for the quantification of interstitial fibrosis in renal transplantation. Transplantation (2011) 0.90
Mycophenolate sodium-induced hepatotoxicity: first report. Transplantation (2006) 0.90
Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol (2010) 0.89
Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation (2009) 0.89
Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Baltimore) (2003) 0.89
The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol (2006) 0.89
Eosinophilic annular erythema responsive to chloroquin. Eur J Dermatol (2009) 0.89
Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy. J Am Acad Dermatol (2003) 0.88
Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold. J Clin Endocrinol Metab (2013) 0.87
[Henoch-Shönlein purpura]. Nephrol Ther (2009) 0.86
Effects of cinacalcet in renal transplant patients with hyperparathyroidism. Am J Nephrol (2012) 0.86
A novel POLH gene mutation in a xeroderma pigmentosum-V Tunisian patient: phenotype-genotype correlation. J Genet (2011) 0.86
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression. BMC Cancer (2012) 0.85
[Granulomatosis with polyangiitis (Wegener's granulomatosis)]. Presse Med (2012) 0.85
A French CDK4-positive melanoma family with a co-inherited EDNRB mutation. J Dermatol Sci (2007) 0.85
Response of human renal tubular cells to cyclosporine and sirolimus: a toxicogenomic study. Toxicol Appl Pharmacol (2008) 0.85
Complications of protocol renal biopsy. Transplantation (2004) 0.85
Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis (2002) 0.85
Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study. Transplantation (2011) 0.85
Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol (2004) 0.84
Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update. Pharmacogenomics (2007) 0.84
Tryptophan depletion and the kinase GCN2 mediate IFN-γ-induced autophagy. J Immunol (2012) 0.84
FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis. Nephrol Dial Transplant (2009) 0.84
HNF1B-related diabetes triggered by renal transplantation. Nat Rev Nephrol (2009) 0.84
Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) (2009) 0.84
QUIRKY interacts with STRUBBELIG and PAL OF QUIRKY to regulate cell growth anisotropy during Arabidopsis gynoecium development. Development (2013) 0.83
Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. J Am Acad Dermatol (2007) 0.83
Proteinuria >0.5 g/d, a prevalent prognostic factor for patient and graft survival in kidney transplantation. Clin Transplant (2009) 0.83
Arteriolar hyalinization predicts delayed graft function in deceased donor renal transplantation. Transplantation (2008) 0.83
Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity. Pharmacol Res (2009) 0.83
Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis. Clin J Am Soc Nephrol (2011) 0.83
Rapamycin-induced oligospermia. Transplantation (2003) 0.82
Sirolimus early graft nephrotoxicity: clinical and experimental data. Curr Drug Saf (2006) 0.82
Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report. Nephrol Dial Transplant (2011) 0.82
Thiopurine methyltransferase activity: new conditions for reversed-phase high-performance liquid chromatographic assay without extraction and genotypic-phenotypic correlation. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.82
Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study. Transplantation (2010) 0.82
Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor. Transplantation (2008) 0.81
Home and office blood pressure monitoring in renal transplant recipients. J Transplant (2012) 0.81
Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation (2004) 0.81
Performance of GFR estimating equations in African Europeans: basis for a lower race-ethnicity factor than in African Americans. Am J Kidney Dis (2013) 0.81
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. Br J Cancer (2008) 0.81